Redirecting to our new website
here !
AI/EID Studies in year 2008
Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV). Mihajlovic ML, Mitrasinovic PM.
Antimicrobial Drug Resistance in Human Nontyphoidal Salmonella Isolates in Europe 2000–2004: A Report from the Enter-net International Surveillance Network Sally Meakins, Ian S.T. Fisher, Christian Berghold, Peter Gerner-Smidt, Helmut Tschäpe, Martin Cormican, Ida Luzzi, Francois Schneider, Wim Wannett, John Coia, Aurora Echeita, and E. John Threlfa
Development of a reliable assay protocol for identification of diseases (RAPID)-bioactive amplification with probing (BAP) for detection of Newcastle disease virus Wang CY, Hsu CJ, Chen HJ, Chulu JL, Liu HJ.
Genetic characterization of avian influenza viruses isolated from waterfowl in southern part of South Korea in 2006 Kim HM, Oh JH, Seo SH.
Global Factors Driving Emerging Infectious Diseases Aguirre, A. A. and Tabor, G. M.
Global trends in emerging infectious diseases Kate E. Jones, Nikkita G. Patel, Marc A. Levy, Adam Storeygard, Deborah Balk, John L. Gittleman & Peter Daszak
H2N5 influenza virus isolates from terns in Australia: genetic reassortants between those of the Eurasian and American lineages. Kishida N et al.
H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens Li C. et al.
H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens. C, Ping J, Jing B, Deng G, Jiang Y, Li Y, Tian G, Yu K, Bu Z, Chen H.
Inactivation and morphological changes of avian influenza virus by copper ions. Horie M, Ogawa H, Yoshida Y, Yamada K, Hara A, Ozawa K, Matsuda S, Mizota C,
Tani M, Yamamoto Y, Yamada M, Nakamura K, Imai K.
1 2
APEIR Coordinating Office
Web Developer: Boontium Kongsaktrakoon. Bangkok, Thailand. (boontium_k@hotmail.com)
